Medytox Inc., 10% Owner at Evolus, Inc. (EOLS), bought 160,000 shares at $10.54 ($1.7M) on 2021-08-18, disclosed to the SEC on 2021-08-19.
Open-market purchase of $1.7M EOLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.69 | 70,000 | $748K | 44.1% |
| 2 | $10.54 | 45,000 | $474K | 28.0% |
| 3 | $10.54 | 45,000 | $474K | 28.0% |
| Total | $10.61 avg | 160,000 | $1.7M | 100% |
| Filing → |
| EOLS | BUY | 2023-02-06 | $565K | — | Filing → |
| EOLS | SELL | 2023-02-06 | $818K | — | Filing → |
| EOLS | SELL | 2022-10-07 | $689K | — | Filing → |